X0303 4 2009-10-15 1 0000005187 WYETH WYE 0001450730 Kamarck Michael E. 5 GIRALDA FARMS MADISON NJ 07940 0 1 0 0 President, TO&PS Common Stock 2009-10-15 4 D 0 30495 D 0 D Employee Stock Option 62.40 2009-10-15 4 D 0 30000 0.00 D Common Stock 30000 0 D Employee Stock Option 60.705 2009-10-15 4 D 0 45000 0.00 D Common Stock 45000 0 D Employee Stock Option 34.675 2009-10-15 4 D 0 2 14.905 D Common Stock 2 0 D Employee Stock Option 41.05 2009-10-15 4 D 0 7500 8.53 D Common Stock 7500 0 D Employee Stock Option 40.22 2009-10-15 4 D 0 2486 9.36 D Common Stock 2486 0 D Employee Stock Option 43.57 2009-10-15 4 D 0 31190 6.01 D Common Stock 31190 0 D Employee Stock Option 48.22 2009-10-15 4 D 0 31200 1.36 D Common Stock 31200 0 D Employee Stock Option 56.00 2009-10-15 4 D 0 31200 0.00 D Common Stock 31200 0 D Employee Stock Option 44.56 2009-10-15 4 D 0 35000 5.02 D Common Stock 35000 0 D Pursuant to the Agreement and Plan of Merger by and among Wyeth, Pfizer Inc. and Wagner Acquisition Corp., dated as of January 25, 2009 (as amended, the "Merger Agreement"), each of these shares was cancelled at the effective time of the merger and converted into the right to receive $33.00 in cash and 0.985 of a share of Pfizer Inc. common stock, less any applicable tax withholding. Includes 8,280 restricted stock units that received the above merger consideration deferred into a rabbi trust. Pursuant to the Merger Agreement, each outstanding and unexercised option, whether vested or unvested, was cancelled at the effective time of the merger in exchange for cash equal to the product of (a) the number of shares underlying such option and (b) the excess, if any, of the per share value of the merger consideration of $49.58 over the per share exercise price of the option, less any applicable tax withholding. Tara J. Gabbai, Attorney-in-Fact for Michael E. Kamarck 2009-10-19